CRCNS: Collaboration toward an experimentally validated multiscale model of rTMS
Mental health diseases such as depression are a major burden on society and new treatment options are strongly needed. One strategic goal of NIMH is to develop novel therapies based on discoveries in neuroscience. TMS is a non-invasive neuromodulation technique that can directly interfere with brain activity. TMS is FDA-approved for depression treatment, however, shows mixed efficacy.